“Harnessing Immune Checkpoint Inhibitors Against Gastric Cancer: Charting the Course to Expanded Therapeutic Benefit”, Biomed. Res. Ther., vol. 11, no. 4, pp. 6305–6325, Apr. 2024, doi: 10.15419/bmrat.v11i4.877.